Group One Trading’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Buy
44,900
+42,300
+1,627% +$4.27M 0.01% 1404
2025
Q4
$207K Sell
2,600
-48,000
-95% -$3.15M ﹤0.01% 4339
2025
Q3
$2.36M Sell
50,600
-8,500
-14% -$333K ﹤0.01% 2144
2025
Q2
$2.17M Buy
59,100
+27,500
+87% +$1.06M ﹤0.01% 2059
2025
Q1
$1.12M Sell
31,600
-44,500
-58% -$1.81M ﹤0.01% 2362
2024
Q4
$3.33M Sell
76,100
-23,600
-24% -$1.19M 0.01% 1470
2024
Q3
$4.52M Buy
99,700
+74,700
+299% +$3.25M 0.01% 1073
2024
Q2
$970K Sell
25,000
-1,500
-6% -$56.1K ﹤0.01% 2001
2024
Q1
$854K Sell
26,500
-13,400
-34% -$397K ﹤0.01% 2229
2023
Q4
$1.14M Buy
39,900
+5,800
+17% +$139K ﹤0.01% 2346
2023
Q3
$944K Buy
34,100
+9,100
+36% +$270K ﹤0.01% 2323
2023
Q2
$669K Buy
25,000
+24,300
+3,471% +$596K ﹤0.01% 2735
2023
Q1
$15.2K Buy
+700
New +$17.2K ﹤0.01% 5698
2022
Q4
Sell
-25,000
Closed -$493K 7982
2022
Q3
$493K Hold
25,000
﹤0.01% 3254
2022
Q2
$487K Sell
25,000
-100
-0.4% -$1.95K ﹤0.01% 3450
2022
Q1
$640K Buy
+25,100
New +$546K ﹤0.01% 3555
2021
Q3
Sell
-200
Closed -$6K 8710
2021
Q2
$6K Buy
+200
New +$6.98K ﹤0.01% 7713

Other funds holding RVMD

Group One Trading's RVMD Position: Q1 2026 in Review

Group One Trading sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 40,145 shares — an estimated $4.05M sold.

Group One Trading first reported a position in RVMD in Q2 2022 and held it in 9 quarters. The position peaked at $3.2M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Group One Trading reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 40,145 Revolution Medicines shares in Q1 2026, an estimated $4.05M.
  • Group One Trading first reported a position in Revolution Medicines in Q2 2022 and held it in 9 quarters.
  • Group One Trading's Revolution Medicines position peaked at $3.2M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.